| Organism name | Bos taurus domesticus GMELIN |
|---|---|
| Genus | Bos |
| Family | Bovidae |
| Kingdom | Animalia |
| Linked NCBI taxonomy name | Bos |
|---|---|
| Linked NCBI taxonomy ID | 9903 |
| Linked level | genus |
| Family in NCBI taxonomy | Bovidae |
|---|---|
| ID | 9895 |
| Kingdom (Superkingdom) in NCBI taxonomy | Metazoa |
|---|---|
| ID | 33208 |
| Plant class | |
|---|---|
| ID |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00029948
|
Methyl chlorogenate
/ Methyl 5-O-caffeoylquinate / Chlorogenic acid methyl ester |
CHEMBL416955
CHEMBL596924 CHEMBL1765881 CHEMBL1765882 CHEMBL2048503 CHEMBL2349427 |
6 / 5 / 4 | No. 314 | No. 6 |
|
||
|
C00032464
|
Ursodeoxycholic acid
|
CHEMBL156266
CHEMBL240597 CHEMBL1551 CHEMBL1395373 CHEMBL1439625 CHEMBL1520183 CHEMBL1981518 CHEMBL1988085 CHEMBL2074643 |
D014580
|
31 / 42 / 36 | 120 / 39 | No. 2182 |
|
|
|
C00030498
|
Hyodeoxycholic acid
|
CHEMBL272620
CHEMBL272621 CHEMBL1473584 CHEMBL2359483 |
C010471
|
13 / 14 / 5 | 2 / 0 | No. 2182 |
|
|
|
C00030117
|
Deoxycholic acid
/ 3alpha,12alpha-Dihydroxy-5.beta.-cholanoic acid |
CHEMBL348338
CHEMBL412516 CHEMBL410872 CHEMBL406393 CHEMBL1609669 CHEMBL2078862 CHEMBL2092842 CHEMBL2356050 |
D003840
|
16 / 7 / 7 | 44 / 12 | No. 2182 |
|
|
|
C00029828
|
Bilirubin
/ (Z,Z)-Bilirubin |
CHEMBL501680
|
D001663
|
22 / 31 / 28 | 155 / 20 | No. 6732 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00030117 C00030498 C00032464 | 1 / 1 |
| Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00030117 C00030498 C00032464 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00030117 C00032464 | 1 / 1 |
| O75795 | UDP-glucuronosyltransferase 2B17 | Enzyme | C00029828 C00030498 | 1 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00029828 C00032464 | 1 / 1 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00029828 C00032464 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00029828 C00030498 | 4 / 3 |
| O95342 | Bile salt export pump | drug | C00030117 C00032464 | 2 / 1 |
| P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00029828 C00030498 | 5 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00030117 C00032464 | 0 / 1 |
| O00255 | Menin | Unclassified protein | C00029828 C00032464 | 2 / 5 |
| P06133 | UDP-glucuronosyltransferase 2B4 | Enzyme | C00030498 C00032464 | 0 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00030117 C00032464 | 0 / 0 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00029828 C00032464 | 1 / 2 |
| P02545 | Prelamin-A/C | Unclassified protein | C00029828 C00032464 | 11 / 10 |
| Q12908 | Ileal sodium/bile acid cotransporter | Bile acid | C00030117 C00032464 | 1 / 1 |
| P46721 | Solute carrier organic anion transporter family member 1A2 | Unclassified protein | C00029828 C00032464 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00030117 C00032464 | 0 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00030117 C00032464 | 0 / 1 |
| P16662 | UDP-glucuronosyltransferase 2B7 | Enzyme | C00029828 C00030498 | 0 / 0 |
| Q14973 | Sodium/bile acid cotransporter | Bile acid | C00030117 C00032464 | 0 / 0 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00030117 C00032464 | 1 / 0 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00029828 | 2 / 3 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00029828 | 0 / 0 |
| Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | C00030498 | 0 / 0 |
| P02768 | Serum albumin | Secreted protein | C00032464 | 0 / 0 |
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00030498 | 3 / 1 |
| O15439 | Multidrug resistance-associated protein 4 | Unclassified protein | C00032464 | 0 / 0 |
| O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00029828 | 0 / 0 |
| P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00030498 | 0 / 0 |
| P03956 | Interstitial collagenase | M10A | C00029948 | 0 / 1 |
| P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00032464 | 7 / 3 |
| P37840 | Alpha-synuclein | Unclassified protein | C00032464 | 4 / 2 |
| Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00029828 | 1 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00029828 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00032464 | 0 / 1 |
| P45452 | Collagenase 3 | M10A | C00029948 | 1 / 1 |
| Q96RI1 | Bile acid receptor | NR1H4 | C00032464 | 0 / 0 |
| P18433 | Receptor-type tyrosine-protein phosphatase alpha | Receptor tyrosine-protein phosphatase | C00030117 | 0 / 0 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00030117 | 0 / 0 |
| P08253 | 72 kDa type IV collagenase | M10A | C00029948 | 1 / 3 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00029828 | 3 / 3 |
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00032464 | 1 / 1 |
| Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00030498 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00029948 | 2 / 2 |
| P36537 | UDP-glucuronosyltransferase 2B10 | Enzyme | C00030498 | 0 / 0 |
| P23467 | Receptor-type tyrosine-protein phosphatase beta | Receptor tyrosine-protein phosphatase | C00030117 | 0 / 0 |
| P55210 | Caspase-7 | C14 | C00029828 | 0 / 0 |
| P39900 | Macrophage metalloelastase | M10A | C00029948 | 0 / 0 |
| P29466 | Caspase-1 | C14 | C00029828 | 0 / 0 |
| P04062 | Glucosylceramidase | Enzyme | C00032464 | 6 / 4 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00032464 | 2 / 0 |
| P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00029828 | 0 / 0 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00030117 | 0 / 0 |
| P08235 | Mineralocorticoid receptor | NR3C2 | C00032464 | 2 / 2 |
| P31939 | Bifunctional purine biosynthesis protein PURH | Enzyme | C00030117 | 1 / 1 |
| P08254 | Stromelysin-1 | M10A | C00029948 | 1 / 0 |
| P04054 | Phospholipase A2 | Enzyme | C00032464 | 0 / 0 |
| Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00030498 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00029828 | 0 / 0 |
| Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00029828 | 1 / 0 |
| P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00029828 | 3 / 0 |
| O75469 | Nuclear receptor subfamily 1 group I member 2 | NR1I2 | C00032464 | 0 / 0 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00032464 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00029828
C00030117
C00032464
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00029828
C00030117
C00032464
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00029828
C00030117
C00032464
|
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00029828
C00032464
|
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00030117
C00032464
|
| 9971 | NR1H4, BAR, FXR, HRR-1, HRR1, RIP14 | nuclear receptor subfamily 1, group H, member 4 |
C00030117
C00032464
|
| 374 | AREG, AR, CRDGF, SDGF | amphiregulin |
C00029828
C00030117
|
| 4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00030117
C00032464
|
| 3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00030117
C00032464
|
| 9965 | FGF19 | fibroblast growth factor 19 |
C00030117
C00032464
|
| 2172 | FABP6, I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP | fatty acid binding protein 6, ileal |
C00030117
C00032464
|
| 1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00030117
C00032464
|
| 1581 | CYP7A1, CP7A, CYP7, CYPVII | cytochrome P450, family 7, subfamily A, polypeptide 1 (EC:1.14.13.17) |
C00030117
C00032464
|
| 1051 | CEBPB, C/EBP-beta, CRP2, IL6DBP, LAP, LIP, NF-IL6, TCF5 | CCAAT/enhancer binding protein (C/EBP), beta |
C00030117
C00032464
|
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00030117
C00032464
|
| 839 | CASP6, MCH2 | caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) |
C00030117
C00032464
|
| 5579 | PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2 | protein kinase C, beta (EC:2.7.11.13) |
C00030117
C00032464
|
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00030117
C00032464
|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00030117
C00032464
|
| 8647 | ABCB11, ABC16, BRIC2, BSEP, PFIC-2, PFIC2, PGY4, SPGP | ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
C00030117
C00032464
|
| 9962 | SLC23A2, NBTL1, SLC23A1, SVCT2, YSPL2 | solute carrier family 23 (ascorbic acid transporter), member 2 |
C00029828
C00032464
|
| 9963 | SLC23A1, SLC23A2, SVCT1, YSPL3 | solute carrier family 23 (ascorbic acid transporter), member 1 |
C00029828
C00032464
|
| 22836 | RHOBTB3 | Rho-related BTB domain containing 3 |
C00029828
C00032464
|
| 10549 | PRDX4, AOE37-2, PRX-4 | peroxiredoxin 4 (EC:1.11.1.15) |
C00029828
C00030117
|
| 8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00029828
C00032464
|
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00030117
C00032464
|
| 5894 | RAF1, CRAF, NS5, Raf-1, c-Raf | v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) |
C00030117
C00032464
|
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00029828
C00032464
|
| 3309 | HSPA5, BIP, GRP78, MIF2 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
C00029828
C00030117
|
| 3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00029828
C00030117
|
| 2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00029828
C00030117
|
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00029828
C00032464
|
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00029828
C00032464
|
| 406991 | MIR21, MIRN21, hsa-mir-21, miR-21, miRNA21 | microRNA 21 |
C00032464
|
| 1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00029828
|
| 1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00029828
|
| 1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00029828
|
| 420357 |
C00029828
|
||
| 93099 | DMKN, UNQ729, ZD52F10 | dermokine |
C00029828
|
| 3337 | DNAJB1, HSPF1, Hdj1, Hsp40, RSPH16B, Sis1 | DnaJ (Hsp40) homolog, subfamily B, member 1 |
C00029828
|
| 23549 | DNPEP, ASPEP, DAP | aspartyl aminopeptidase (EC:3.4.11.21) |
C00029828
|
| 23333 | DPY19L1 | dpy-19-like 1 (C. elegans) |
C00029828
|
| 1847 | DUSP5, DUSP, HVH3 | dual specificity phosphatase 5 (EC:3.1.3.16 3.1.3.48) |
C00029828
|
| 54583 | EGLN1, C1orf12, ECYT3, HIF-PH2, HIFPH2, HPH-2, HPH2, PHD2, SM20, ZMYND6 | egl-9 family hypoxia-inducible factor 1 (EC:1.14.11.29) |
C00029828
|
| 9538 | EI24, EPG4, PIG8, TP53I8 | etoposide induced 2.4 |
C00029828
|
| 23741 | EID1, C15orf3, CRI1, EID-1, IRO45620, PTD014, RBP21 | EP300 interacting inhibitor of differentiation 1 |
C00029828
|
| 9451 | EIF2AK3, PEK, PERK, WRS | eukaryotic translation initiation factor 2-alpha kinase 3 (EC:2.7.11.1) |
C00029828
|
| 1965 | EIF2S1, EIF-2, EIF-2A, EIF-2alpha, EIF2, EIF2A | eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
C00029828
|
| 23052 | ENDOD1 | endonuclease domain containing 1 |
C00029828
|
| 345757 | FAM174A, TMEM157, UNQ1912 | family with sequence similarity 174, member A |
C00029828
|
| 8061 | FOSL1, FRA, FRA1, fra-1 | FOS-like antigen 1 |
C00029828
|
| 4616 | GADD45B, GADD45BETA, MYD118 | growth arrest and DNA-damage-inducible, beta |
C00029828
|
| 60674 | GAS5, NCRNA00030, SNHG2 | growth arrest-specific 5 (non-protein coding) |
C00029828
|
| 2934 | GSN, ADF, AGEL | gelsolin |
C00029828
|
| 2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00029828
|
| 2939 | GSTA2, GST2, GSTA2-2, GTA2, GTH2 | glutathione S-transferase alpha 2 (EC:2.5.1.18) |
C00029828
|
| 2940 | GSTA3, GSTA3-3, GTA3 | glutathione S-transferase alpha 3 (EC:2.5.1.18) |
C00029828
|
| 2941 | GSTA4, GSTA4-4, GTA4 | glutathione S-transferase alpha 4 (EC:2.5.1.18) |
C00029828
|
| 373156 | GSTK1, GST, GST_13-13, GST13, GST13-13, GSTK1-1, hGSTK1 | glutathione S-transferase kappa 1 (EC:2.5.1.18) |
C00029828
|
| 2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00029828
|
| 2920 | CXCL2, CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, MIP2, MIP2A, SCYB2 | chemokine (C-X-C motif) ligand 2 |
C00029828
|
| 9843 | HEPH, CPL | hephaestin |
C00029828
|
| 9709 | HERPUD1, HERP, Mif1, SUP | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
C00029828
|
| 3008 | HIST1H1E, H1.4, H1E, H1F4, H1s-4, dJ221C16.5 | histone cluster 1, H1e |
C00029828
|
| 8347 | HIST1H2BC, H2B.1, H2B/l, H2BFL, dJ221C16.3 | histone cluster 1, H2bc |
C00029828
|
| 319188 |
C00029828
|
||
| 8294 | HIST1H4I, H4/m, H4FM, H4M | histone cluster 1, H4i |
C00029828
|
| 97114 |
C00029828
|
||
| 92815 | HIST3H2A | histone cluster 3, H2a |
C00029828
|
| 6373 | CXCL11, H174, I-TAC, IP-9, IP9, SCYB11, SCYB9B, b-R1 | chemokine (C-X-C motif) ligand 11 |
C00029828
|
| 373300 |
C00029828
|
||
| 3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00029828
|
| 3418 | IDH2, D2HGA2, ICD-M, IDH, IDHM, IDP, IDPM, mNADP-IDH | isocitrate dehydrogenase 2 (NADP+), mitochondrial (EC:1.1.1.42) |
C00029828
|
| 3475 | IFRD1, PC4, TIS7 | interferon-related developmental regulator 1 |
C00029828
|
| 3486 | IGFBP3, BP-53, IBP3 | insulin-like growth factor binding protein 3 |
C00029828
|
| 3606 | IL18, IGIF, IL-18, IL-1g, IL1F4 | interleukin 18 (interferon-gamma-inducing factor) |
C00029828
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00029828
|
| 1512 | CTSH, ACC-4, ACC-5, CPSB, minichain | cathepsin H (EC:3.4.22.16) |
C00029828
|
| 3912 | LAMB1, CLM, LIS5 | laminin, beta 1 |
C00029828
|
| 3920 | LAMP2, CD107b, LAMP-2, LAMPB, LGP110 | lysosomal-associated membrane protein 2 |
C00029828
|
| 54741 | LEPROT, LEPR, OB-RGRP, OBRGRP, VPS55 | leptin receptor overlapping transcript |
C00029828
|
| 3976 | LIF, CDF, DIA, HILDA, MLPLI | leukemia inhibitory factor |
C00029828
|
| 4035 | LRP1, A2MR, APOER, APR, CD91, IGFBP3R, LRP, LRP1A, TGFBR5 | low density lipoprotein receptor-related protein 1 |
C00029828
|
| 110454 |
C00029828
|
||
| 4094 | MAF, CCA4, c-MAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
C00029828
|
| 1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00029828
|
| 1362 | CPD, GP180 | carboxypeptidase D (EC:3.4.17.22) |
C00029828
|
| 10982 | MAPRE2, EB1, EB2, RP1 | microtubule-associated protein, RP/EB family, member 2 |
C00029828
|
| 4200 | ME2, ODS1 | malic enzyme 2, NAD(+)-dependent, mitochondrial (EC:1.1.1.38) |
C00029828
|
| 1955 | MEGF9, EGFL5 | multiple EGF-like-domains 9 |
C00029828
|
| 4258 | MGST2, GST2, MGST-II | microsomal glutathione S-transferase 2 (EC:2.5.1.18) |
C00029828
|
| 4322 | MMP13, CLG3, MANDP1 | matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) |
C00029828
|
| 10205 | MPZL2, EVA, EVA1 | myelin protein zero-like 2 |
C00029828
|
| 29074 | MRPL18, L18mt, MRP-L18 | mitochondrial ribosomal protein L18 |
C00029828
|
| 4811 | NID1, NID | nidogen 1 |
C00029828
|
| 23530 | NNT, GCCD4 | nicotinamide nucleotide transhydrogenase (EC:1.6.1.2) |
C00029828
|
| 1355 | COX15, CEMCOX2 | cytochrome c oxidase assembly homolog 15 (yeast) |
C00029828
|
| 9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00029828
|
| 29948 | OSGIN1, BDGI, OKL38 | oxidative stress induced growth inhibitor 1 |
C00029828
|
| 5163 | PDK1 | pyruvate dehydrogenase kinase, isozyme 1 (EC:2.7.11.2) |
C00029828
|
| 27315 | PGAP2, CWH43-N, FRAG1, HPMRS3, MRT17, MRT21 | post-GPI attachment to proteins 2 |
C00029828
|
| 5245 | PHB, PHB1 | prohibitin |
C00029828
|
| 8554 | PIAS1, DDXBP1, GBP, GU/RH-II, ZMIZ3 | protein inhibitor of activated STAT, 1 |
C00029828
|
| 5295 | PIK3R1, AGM7, GRB1, p85, p85-ALPHA | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
C00029828
|
| 18722 |
C00029828
|
||
| 51365 | PLA1A, PS-PLA1, PSPLA1 | phospholipase A1 member A (EC:3.1.1.-) |
C00029828
|
| 5376 | PMP22, CMT1A, CMT1E, DSS, GAS-3, HMSNIA, HNPP, Sp110 | peripheral myelin protein 22 |
C00029828
|
| 5445 | PON2 | paraoxonase 2 (EC:3.1.1.2 3.1.1.81) |
C00029828
|
| 1281 | COL3A1, EDS4A | collagen, type III, alpha 1 |
C00029828
|
| 5728 | PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1 | phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) |
C00029828
|
| 401494 | PTPLAD2, HACD4 | protein tyrosine phosphatase-like A domain containing 2 (EC:4.2.1.134) |
C00029828
|
| 83937 | RASSF4, AD037 | Ras association (RalGDS/AF-6) domain family member 4 |
C00029828
|
| 9584 | RBM39, CAPER, CAPERalpha, FSAP59, HCC1, RNPC2 | RNA binding motif protein 39 |
C00029828
|
| 10181 | RBM5, G15, LUCA15, RMB5 | RNA binding motif protein 5 |
C00029828
|
| 6249 | CLIP1, CLIP, CLIP-170, CLIP170, CYLN1, RSN | CAP-GLY domain containing linker protein 1 |
C00029828
|
| 6038 | RNASE4, RNS4 | ribonuclease, RNase A family, 4 (EC:3.1.27.-) |
C00029828
|
| 6281 | S100A10, 42C, ANX2L, ANX2LG, CAL1L, CLP11, Ca[1], GP11, P11, p10 | S100 calcium binding protein A10 |
C00029828
|
| 6275 | S100A4, 18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98 | S100 calcium binding protein A4 |
C00029828
|
| 6342 | SCP2, NLTP, NSL-TP, SCP-2, SCP-CHI, SCP-X, SCPX | sterol carrier protein 2 (EC:2.3.1.176) |
C00029828
|
| 8991 | SELENBP1, LPSB, SBP56, SP56, hSBP | selenium binding protein 1 |
C00029828
|
| 66222 |
C00029828
|
||
| 5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00029828
|
| 27244 | SESN1, PA26, SEST1 | sestrin 1 |
C00029828
|
| 81537 | SGPP1, SPPase1 | sphingosine-1-phosphate phosphatase 1 |
C00029828
|
| 387700 | SLC16A12, CJMG, MCT12 | solute carrier family 16, member 12 |
C00029828
|
| 23155 | CLCC1, MCLC | chloride channel CLIC-like 1 |
C00029828
|
| 1119 | CHKA, CHK, CK, CKI, EK | choline kinase alpha (EC:2.7.1.32 2.7.1.82) |
C00029828
|
| 6520 | SLC3A2, 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE | solute carrier family 3 (amino acid transporter heavy chain), member 2 |
C00029828
|
| 23657 | SLC7A11, CCBR1, xCT | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
C00029828
|
| 10599 | SLCO1B1, HBLRR, LST-1, LST1, OATP-C, OATP1B1, OATP2, OATPC, SLC21A6 | solute carrier organic anion transporter family, member 1B1 |
C00029828
|
| 57231 | SNX14, RGS-PX2 | sorting nexin 14 |
C00029828
|
| 50964 | SOST, CDD, VBCH | sclerostin |
C00029828
|
| 389058 | SP5 | Sp5 transcription factor |
C00029828
|
| 73526 |
C00029828
|
||
| 6892 | TAPBP, NGS17, TAPA, TPN, TPSN | TAP binding protein (tapasin) |
C00029828
|
| 6925 | TCF4, E2-2, ITF-2, ITF2, PTHS, SEF-2, SEF2, SEF2-1, SEF2-1A, SEF2-1B, TCF-4, bHLHb19 | transcription factor 4 |
C00029828
|
| 25976 | TIPARP, ARTD14, PARP7, pART14 | TCDD-inducible poly(ADP-ribose) polymerase (EC:2.4.2.30) |
C00029828
|
| 9375 | TM9SF2, P76 | transmembrane 9 superfamily member 2 |
C00029828
|
| 55504 | TNFRSF19, TAJ, TAJ-alpha, TRADE, TROY | tumor necrosis factor receptor superfamily, member 19 |
C00029828
|
| 1200 | TPP1, CLN2, LPIC, TPP-1 | tripeptidyl peptidase I (EC:3.4.14.9) |
C00029828
|
| 28951 | TRIB2, C5FW, GS3955, TRB2 | tribbles pseudokinase 2 |
C00029828
|
| 7329 | UBE2I, C358B7.1, P18, UBC9 | ubiquitin-conjugating enzyme E2I (EC:6.3.2.19) |
C00029828
|
| 54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00029828
|
| 54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00029828
|
| 7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00029828
|
| 708396 |
C00029828
|
||
| 7381 | UQCRB, MC3DN3, QCR7, QP-C, QPC, UQBC, UQBP, UQCR6, UQPC | ubiquinol-cytochrome c reductase binding protein (EC:1.10.2.2) |
C00029828
|
| 7384 | UQCRC1, D3S3191, QCR1, UQCR1 | ubiquinol-cytochrome c reductase core protein I (EC:1.10.2.2) |
C00029828
|
| 7388 | UQCRH, QCR6, UQCR8 | ubiquinol-cytochrome c reductase hinge protein (EC:1.10.2.2) |
C00029828
|
| 80146 | UXS1, SDR6E1, UGD | UDP-glucuronate decarboxylase 1 (EC:4.1.1.35) |
C00029828
|
| 7436 | VLDLR, CARMQ1, CHRMQ1, VLDLRCH | very low density lipoprotein receptor |
C00029828
|
| 26137 | ZBTB20, DPZF, HOF, ODA-8S, ZNF288 | zinc finger and BTB domain containing 20 |
C00029828
|
| 339487 | ZBTB8OS, ARCH, ARCH2 | zinc finger and BTB domain containing 8 opposite strand |
C00029828
|
| 84186 | ZCCHC7, AIR1, RP11-397D12.1 | zinc finger, CCHC domain containing 7 |
C00029828
|
| 90637 | ZFAND2A, AIRAP | zinc finger, AN1-type domain 2A |
C00029828
|
| 22680 |
C00029828
|
||
| 24132 |
C00029828
|
||
| 79094 | CHAC1 | ChaC, cation transport regulator homolog 1 (E. coli) |
C00029828
|
| 8714 | ABCC3, ABC31, EST90757, MLP2, MOAT-D, MRP3, cMOAT2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
C00030117
|
| 9936 | CD302, BIMLEC, CLEC13A, DCL-1, DCL1 | CD302 molecule |
C00029828
|
| 664 | BNIP3, NIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
C00030117
|
| 25819 | CCRN4L, CCR4L, NOC | CCR4 carbon catabolite repression 4-like (S. cerevisiae) |
C00029828
|
| 151887 | CCDC80, DRO1, SSG1, URB, okuribin | coiled-coil domain containing 80 |
C00029828
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00029828
|
| 10438 | C1D, LRP1, SUN-CoR, SUNCOR, hC1D | C1D nuclear receptor corepressor |
C00029828
|
| 2647 | BLOC1S1, BLOS1, GCN5L1, MICoA, RT14 | biogenesis of lysosomal organelles complex-1, subunit 1 |
C00029828
|
| 8313 | AXIN2, AXIL, ODCRCS | axin 2 |
C00029828
|
| 476 | ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9) |
C00029828
|
| 467 | ATF3 | activating transcription factor 3 |
C00029828
|
| 2978 | GUCA1A, C6orf131, COD3, CORD14, GCAP, GCAP1, GUCA, GUCA1, dJ139D8.6 | guanylate cyclase activator 1A (retina) |
C00030117
|
| 79754 | ASB13 | ankyrin repeat and SOCS box containing 13 |
C00029828
|
| 3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00030117
|
| 5654 | HTRA1, ARMD7, CARASIL, HtrA, L56, ORF480, PRSS11 | HtrA serine peptidase 1 (EC:3.4.21.-) |
C00030117
|
| 4000 | LMNA, CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL, FPLD, FPLD2, HGPS, IDC, LDP1, LFP, LGMD1B, LMN1, LMNC, LMNL1, PRO1 | lamin A/C |
C00030117
|
| 4671 | NAIP, BIRC1, NLRB1, psiNAIP | NLR family, apoptosis inhibitory protein |
C00030117
|
| 9411 | ARHGAP29, PARG1, RP11-255E17.1 | Rho GTPase activating protein 29 |
C00029828
|
| 4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00030117
|
| 301 | ANXA1, ANX1, LPC1 | annexin A1 |
C00029828
|
| 4893 | NRAS, ALPS4, N-ras, NRAS1, NS6 | neuroblastoma RAS viral (v-ras) oncogene homolog |
C00030117
|
| 210 | ALAD, ALADH, PBGS | aminolevulinate dehydratase (EC:4.2.1.24) |
C00029828
|
| 23396 | PIP5K1C, LCCS3, PIP5K-GAMMA, PIP5Kgamma, PIPKIg_v4 | phosphatidylinositol-4-phosphate 5-kinase, type I, gamma (EC:2.7.1.68) |
C00030117
|
| 7001 | PRDX2, NKEF-B, NKEFB, PRP, PRX2, PRXII, PTX1, TDPX1, TPX1, TSA | peroxiredoxin 2 (EC:1.11.1.15) |
C00030117
|
| 5564 | PRKAB1, AMPK, HAMPKb | protein kinase, AMP-activated, beta 1 non-catalytic subunit |
C00030117
|
| 7363 | UGT2B4, HLUG25, UDPGT2B4, UDPGTH1, UGT2B11 | UDP glucuronosyltransferase 2 family, polypeptide B4 (EC:2.4.1.17) |
C00030498
|
| 5581 | PRKCE, PKCE, nPKC-epsilon | protein kinase C, epsilon (EC:2.7.11.13) |
C00030117
|
| 5590 | PRKCZ, PKC-ZETA, PKC2 | protein kinase C, zeta (EC:2.7.11.13) |
C00030117
|
| 4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00029828
|
| 7364 | UGT2B7, UDPGT_2B9, UDPGT2B7, UDPGTH2, UGT2B9 | UDP glucuronosyltransferase 2 family, polypeptide B7 (EC:2.4.1.17) |
C00030498
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00030117
|
| 5268 | SERPINB5, PI5, maspin | serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
C00030117
|
| 200931 | SLC51A, OSTA, OSTalpha | solute carrier family 51, alpha subunit |
C00030117
|
| 123264 | SLC51B, OSTB, OSTBETA | solute carrier family 51, beta subunit |
C00030117
|
| 7186 | TRAF2, MGC:45012, TRAP, TRAP3 | TNF receptor-associated factor 2 |
C00030117
|
| 5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00032464
|
| 1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00032464
|
| 1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00032464
|
| 1646 | AKR1C2, AKR1C-pseudo, BABP, DD, DD2, DDH2, HAKRD, HBAB, MCDR2, SRXY8 | aldo-keto reductase family 1, member C2 (EC:1.3.1.20 1.1.1.357) |
C00032464
|
| 8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00032464
|
| 23243 | ANKRD28, PITK, PPP1R65 | ankyrin repeat domain 28 |
C00032464
|
| 1173 | AP2M1, AP50, CLAPM1, mu2 | adaptor-related protein complex 2, mu 1 subunit |
C00032464
|
| 335 | APOA1 | apolipoprotein A-I |
C00032464
|
| 55937 | APOM, G3a, HSPC336, NG20, apo-M | apolipoprotein M |
C00032464
|
| 581 | BAX, BCL2L4 | BCL2-associated X protein |
C00032464
|
| 644 | BLVRA, BLVR, BVR, BVRA | biliverdin reductase A (EC:1.3.1.24) |
C00032464
|
| 722 | C4BPA, C4BP, PRP | complement component 4 binding protein, alpha |
C00032464
|
| 840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00032464
|
| 841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00032464
|
| 6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00032464
|
| 6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00032464
|
| 896 | CCND3 | cyclin D3 |
C00032464
|
| 7203 | CCT3, CCT-gamma, CCTG, PIG48, TCP-1-gamma, TRIC5 | chaperonin containing TCP1, subunit 3 (gamma) |
C00032464
|
| 22948 | CCT5, CCT-epsilon, CCTE, TCP-1-epsilon | chaperonin containing TCP1, subunit 5 (epsilon) |
C00032464
|
| 57124 | CD248, CD164L1, TEM1 | CD248 molecule, endosialin |
C00032464
|
| 8837 | CFLAR, CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1, FLAME1, FLIP, I-FLICE, MRIT, c-FLIP, c-FLIPL, c-FLIPR, c-FLIPS | CASP8 and FADD-like apoptosis regulator |
C00032464
|
| 1267 | CNP, CNP1 | 2',3'-cyclic nucleotide 3' phosphodiesterase (EC:3.1.4.37) |
C00032464
|
| 1434 | CSE1L, CAS, CSE1, XPO2 | CSE1 chromosome segregation 1-like (yeast) |
C00032464
|
| 1464 | CSPG4, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2 | chondroitin sulfate proteoglycan 4 |
C00032464
|
| 7818 | DAP3, DAP-3, MRP-S29, MRPS29, bMRP-10 | death associated protein 3 |
C00032464
|
| 1660 | DHX9, DDX9, LKP, NDH2, NDHII, RHA | DEAH (Asp-Glu-Ala-His) box helicase 9 (EC:3.6.4.13) |
C00032464
|
| 1737 | DLAT, DLTA, PDC-E2, PDCE2 | dihydrolipoamide S-acetyltransferase (EC:2.3.1.12) |
C00032464
|
| 10395 | DLC1, ARHGAP7, HP, STARD12, p122-RhoGAP | deleted in liver cancer 1 |
C00032464
|
| 1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00032464
|
| 1907 | EDN2, ET2, PPET2 | endothelin 2 |
C00032464
|
| 10209 | EIF1, A121, EIF-1, EIF1A, ISO1, SUI1 | eukaryotic translation initiation factor 1 |
C00032464
|
| 2033 | EP300, KAT3B, RSTS2, p300 | E1A binding protein p300 (EC:2.3.1.48) |
C00032464
|
| 79956 | ERMP1, FXNA, KIAA1815, bA207C16.3 | endoplasmic reticulum metallopeptidase 1 |
C00032464
|
| 8772 | FADD, MORT1 | Fas (TNFRSF6)-associated via death domain |
C00032464
|
| 26049 | FAM169A, SLAP75 | family with sequence similarity 169, member A |
C00032464
|
| 54537 | FAM35A, FAM35A1, bA163M19.1 | family with sequence similarity 35, member A |
C00032464
|
| 2266 | FGG | fibrinogen gamma chain |
C00032464
|
| 2267 | FGL1, HFREP1, HP-041, LFIRE-1, LFIRE1 | fibrinogen-like 1 |
C00032464
|
| 2617 | GARS, CMT2D, DSMAV, GlyRS, HMN5, SMAD1 | glycyl-tRNA synthetase (EC:6.1.1.14) |
C00032464
|
| 2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00032464
|
| 2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00032464
|
| 100119944 |
C00032464
|
||
| 2937 | GSS, GSHS | glutathione synthetase (EC:6.3.2.3) |
C00032464
|
| 3122 | HLA-DRA, HLA-DRA1, MLRW | major histocompatibility complex, class II, DR alpha |
C00032464
|
| 6927 | HNF1A, HNF-1A, HNF1, IDDM20, LFB1, MODY3, TCF-1, TCF1 | HNF1 homeobox A |
C00032464
|
| 6928 | HNF1B, FJHN, HNF-1B, HNF1beta, HNF2, HPC11, LF-B3, LFB3, MODY5, TCF-2, TCF2, VHNF1 | HNF1 homeobox B |
C00032464
|
| 3385 | ICAM3, CD50, CDW50, ICAM-R | intercellular adhesion molecule 3 |
C00032464
|
| 3458 | IFNG, IFG, IFI | interferon, gamma |
C00032464
|
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00032464
|
| 3615 | IMPDH2, IMPD2, IMPDH-II | IMP (inosine 5'-monophosphate) dehydrogenase 2 (EC:1.1.1.205) |
C00032464
|
| 3713 | IVL | involucrin |
C00032464
|
| 4155 | MBP | myelin basic protein |
C00032464
|
| 4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) |
C00032464
|
| 4193 | MDM2, ACTFS, HDMX, hdm2 | MDM2 oncogene, E3 ubiquitin protein ligase |
C00032464
|
| 1555 | CYP2B6, CPB6, CYP2B, CYP2B7, CYP2B7P, CYPIIB6, EFVM, IIB1, P450 | cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) |
C00029828
|
| 4673 | NAP1L1, NAP1, NAP1L, NRP | nucleosome assembly protein 1-like 1 |
C00032464
|
| 283131 | NEAT1, LINC00084, NCRNA00084, TncRNA, VINC | nuclear paraspeckle assembly transcript 1 (non-protein coding) |
C00032464
|
| 4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00032464
|
| 8431 | NR0B2, SHP, SHP1 | nuclear receptor subfamily 0, group B, member 2 |
C00032464
|
| 220323 | OAF, NS5ATP13TP2 | OAF homolog (Drosophila) |
C00032464
|
| 5005 | ORM2, AGP-B, AGP-B', AGP2 | orosomucoid 2 |
C00032464
|
| 5580 | PRKCD, MAY1, PKCD, nPKC-delta | protein kinase C, delta (EC:2.7.10.2 2.7.11.13) |
C00032464
|
| 5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00032464
|
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00032464
|
| 5930 | RBBP6, MY038, P2P-R, PACT, RBQ-1, SNAMA | retinoblastoma binding protein 6 |
C00032464
|
| 117584 | RFFL, CARP-2, CARP2, FRING, RIFIFYLIN, RNF189, RNF34L | ring finger and FYVE-like domain containing E3 ubiquitin protein ligase |
C00032464
|
| 387 | RHOA, ARH12, ARHA, RHO12, RHOH12 | ras homolog family member A |
C00032464
|
| 8737 | RIPK1, RIP, RIP1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 (EC:2.7.11.1) |
C00032464
|
| 6134 | RPL10, AUTSX5, DXS648, DXS648E, L10, NOV, QM | ribosomal protein L10 |
C00032464
|
| 6155 | RPL27, L27 | ribosomal protein L27 (EC:3.6.5.3) |
C00032464
|
| 6161 | RPL32, L32 | ribosomal protein L32 |
C00032464
|
| 6165 | RPL35A, DBA5, L35A | ribosomal protein L35a |
C00032464
|
| 116832 | RPL39L, RPL39L1 | ribosomal protein L39-like |
C00032464
|
| 6128 | RPL6, L6, SHUJUN-2, TAXREB107, TXREB1 | ribosomal protein L6 |
C00032464
|
| 6181 | RPLP2, D11S2243E, LP2, P2, RPP2 | ribosomal protein, large, P2 |
C00032464
|
| 6207 | RPS13, S13 | ribosomal protein S13 (EC:3.6.5.3) |
C00032464
|
| 51065 | RPS27L | ribosomal protein S27-like |
C00032464
|
| 6234 | RPS28, S28 | ribosomal protein S28 |
C00032464
|
| 145767 |
C00032464
|
||
| 55095 | SAMD4B, SMGB, hSmaug2 | sterile alpha motif domain containing 4B |
C00032464
|
| 23451 | SF3B1, Hsh155, MDS, PRP10, PRPF10, SAP155, SF3b155 | splicing factor 3b, subunit 1, 155kDa |
C00032464
|
| 292 | SLC25A5, 2F1, AAC2, ANT2, T2, T3 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 |
C00032464
|
| 6522 | SLC4A2, AE2, BND3L, EPB3L1, HKB3, NBND3 | solute carrier family 4 (anion exchanger), member 2 |
C00032464
|
| 81848 | SPRY4, HH17 | sprouty homolog 4 (Drosophila) |
C00032464
|
| 6742 | SSBP1, Mt-SSB, SOSS-B1, SSBP, mtSSB | single-stranded DNA binding protein 1, mitochondrial |
C00032464
|
| 6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00032464
|
| 6788 | STK3, KRS1, MST2 | serine/threonine kinase 3 (EC:2.7.11.1) |
C00032464
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00032464
|
| 7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00032464
|
| 8795 | TNFRSF10B, CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFR9 | tumor necrosis factor receptor superfamily, member 10b |
C00032464
|
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00032464
|
| 55339 | WDR33, NET14, WDC146 | WD repeat domain 33 |
C00032464
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
| #608688 | Aicar transformylase/imp cyclohydrolase deficiency |
P31939
|
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
| #613291 | Bile acid malabsorption, primary; pbam |
Q12908
|
| #601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
| #612560 | Bone mineral density quantitative trait locus 12; bmnd12 |
O75795
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #605479 | Cholestasis, benign recurrent intrahepatic, 2; bric2 |
O95342
|
| #601847 | Cholestasis, progressive familial intrahepatic, 2; pfic2 |
O95342
|
| #614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
| #218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
| #606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
| #127750 | Dementia, lewy body; dlb |
P37840
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #237500 | Dubin-johnson syndrome; djs |
Q92887
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #143500 | Gilbert syndrome |
P22309
P22310 |
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
| #237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #605115 | Hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy |
P08235
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #174800 | Mccune-albright syndrome; mas |
P63092
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #166350 | Osseous heteroplasia, progressive; poh |
P63092
|
| #168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
| #605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
P37840 |
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #172700 | Pick disease of brain |
P10636
|
| #102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
| #177735 | Pseudohypoaldosteronism, type i, autosomal dominant; pha1a |
P08235
|
| #103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
| #603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
| #612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
| #145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| KEGG | name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
|
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00624 | Familial cholestasis |
O95342
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00028 | Choriocarcinoma |
P03956
(related)
P08253 (related) |
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
P37840 (related) |
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00243 | Hyperkalemic distal renal tubular acidosis (RTA type 4) |
P08235
(related)
|
| H00603 | Hypertension exacerbated in pregnancy |
P08235
(related)
|
| H00025 | Penile cancer |
P08253
(related)
P14780 (related) |
| H00472 | Torg-Winchester syndrome |
P08253
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
| H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
| H00966 | AICA-ribosiduria |
P31939
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00057 | Parkinson's disease (PD) |
P37840
(related)
|
| H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
| H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
| H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H01016 | Primary bile acid malabsorption |
Q12908
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D009336 | Necrosis |
C00029828
C00030117 C00032464 |
| D056486 | Drug-Induced Liver Injury |
C00029828
C00030117 C00032464 |
| D002780 | Cholestasis, Intrahepatic |
C00029828
C00032464 |
| D002779 | Cholestasis |
C00029828
C00032464 |
| D058739 | Aberrant Crypt Foci |
C00030117
C00032464 |
| D008107 | Liver Diseases |
C00029828
C00032464 |
| D003110 | Colonic Neoplasms |
C00030117
C00032464 |
| D008103 | Liver Cirrhosis |
C00029828
C00032464 |
| D007249 | Inflammation |
C00029828
C00032464 |
| D006980 | Hyperthyroidism |
C00032464
|
| D006975 | Hypertension, Portal |
C00029828
|
| D006505 | Hepatitis |
C00029828
|
| D007567 | Jaundice, Neonatal |
C00029828
|
| D007681 | Kidney Papillary Necrosis |
C00029828
|
| D006504 | Hepatic Veno-Occlusive Disease |
C00029828
|
| D003244 | Consciousness Disorders |
C00029828
|
| D017093 | Liver Failure |
C00029828
|
| D000743 | Anemia, Hemolytic |
C00029828
|
| D012640 | Seizures |
C00029828
|
| D013226 | Status Epilepticus |
C00029828
|
| D054537 | Atrioventricular Block |
C00029828
|
| D001930 | Brain Injuries |
C00030117
|
| D001145 | Arrhythmias, Cardiac |
C00029828
|
| D005911 | Gliosis |
C00030117
|
| D006965 | Hyperplasia |
C00030117
|
| D008113 | Liver Neoplasms |
C00030117
|
| D008114 | Liver Neoplasms, Experimental |
C00030117
|
| D009069 | Movement Disorders |
C00030117
|
| D011230 | Precancerous Conditions |
C00030117
|
| D013274 | Stomach Neoplasms |
C00030117
|
| D001649 | Bile Duct Diseases |
C00032464
|
| D002761 | Cholangitis |
C00032464
|
| D015209 | Cholangitis, Sclerosing |
C00032464
|
| D002769 | Cholelithiasis |
C00032464
|
| C535932 | Cholestasis, intrahepatic of pregnancy |
C00032464
|
| C535933 | Cholestasis, progressive familial intrahepatic 1 |
C00032464
|
| D003550 | Cystic Fibrosis |
C00032464
|
| D005221 | Fatigue |
C00032464
|
| D005234 | Fatty Liver |
C00032464
|
| D005355 | Fibrosis |
C00032464
|
| D005705 | Gallbladder Diseases |
C00032464
|
| D042882 | Gallstones |
C00032464
|
| D019698 | Hepatitis C, Chronic |
C00032464
|
| D006521 | Hepatitis, Chronic |
C00032464
|
| D006943 | Hyperglycemia |
C00032464
|
| D006932 | Hyperbilirubinemia |
C00029828
|
| D007037 | Hypothyroidism |
C00032464
|
| D007333 | Insulin Resistance |
C00032464
|
| D007565 | Jaundice |
C00032464
|
| D041781 | Jaundice, Obstructive |
C00032464
|
| D008105 | Liver Cirrhosis, Biliary |
C00032464
|
| D008106 | Liver Cirrhosis, Experimental |
C00032464
|
| D017114 | Liver Failure, Acute |
C00032464
|
| D009078 | Mucocele |
C00032464
|
| D009369 | Neoplasms |
C00032464
|
| D010195 | Pancreatitis |
C00032464
|
| D017094 | Porphyrias, Hepatic |
C00032464
|
| D011183 | Postoperative Complications |
C00032464
|
| D011537 | Pruritus |
C00032464
|
| D015431 | Weight Loss |
C00032464
|